Research and pharma
Clinical trials, diagnostic research and AI-based drug development.
Viewpoint
November 2026 · 20
In a 400-person trial, the Rosie AI chatbot did not reduce anxiety or depression in pregnant women and new mothersdoctorIn perinatal mental health, a chatbot does not replace professional care; the evidence does not support that.health policyRandomised evidence should be required before funding digital mental health programmes.SK Biopharmaceuticals builds large AI dataset for drug discovery as GaiaBT ties AI to lab validationpharmaceuticalsBuilding proprietary datasets and lab validation are the two decisive elements of AI research.Roche partners with Chai Discovery to deploy Chai-3 model across its pipelinespharmaceuticalsAnother example of large companies integrating external AI molecule-design platforms into their in-house pipelines.Multimodal delirium risk model validated externally and deployable without site-specific retrainingdoctorEarly delirium risk estimation could become part of preventive screening in hospital care.health ITDeployment without retraining may reduce the integration burden.ChemLex raises $45M and launches self-driving lab for drug discovery in SingaporepharmaceuticalsAutomated, AI-driven experimental labs may become available as a service.Semmelweis University researcher discusses detecting type 2 diabetes risk from voicedoctorVoice-based screening could in future supplement the assessment of diabetes risk.AI predicts survival from cardiac MRI scans better than cliniciansdoctorRisk estimation from MRI scans can be automated, which may become a new decision-support tool in cardiology.Drugmaker CEOs doubt AI's promise to cure disease as Sanofi halts a Nurix-partnered programpharmaceuticalsAI-derived candidates must show clinical evidence; promises do not automatically turn into pipeline value.Microsoft's MAI-DxO diagnostic AI agent diagnoses more than twice as accurately as doctorsdoctorDiagnostic AI agents can serve as a second opinion, but the evaluation of their performance applies to controlled conditions.pharmaceuticalsMedical AI agents may reshape diagnostic careers and costs.AI-assisted ultrasound speeds interpretation, flags urgent cases and supports inexperienced staff in cardiac scansdoctorAI-assisted ultrasound combined with remote expert review can extend screening, but medical supervision remains essential.Czech and Swiss surveys: more people turn to AI for health advicedoctorIn the surgery, doctors can increasingly expect patients, especially young ones, to arrive with preliminary information from AI.Google's AI agent can propose new drug molecules within hours, DeepMind sayspharmaceuticalsAgent-based cheminformatics could shorten the time it takes to propose molecules in early-stage research.QUANTRO wins Austrian FFG grant to build AI drug discovery platformpharmaceuticalsA Central European AI drug discovery effort receives public funding.Weill Cornell AI system could prevent testing delays in clinical laboratoriesdoctorEarly warning of laboratory disruptions can lead to faster return of results.health ITMonitoring laboratory operations is a new area for AI applications.Isomorphic Labs in talks to raise about $5 billion for AI drug discoverypharmaceuticalsThe fundraising could intensify competition among AI-native players for partnerships and talent, and the first human trials will serve as a benchmark.Studies and professional bodies warn of harmful mental health and medical advice from AI chatbotsdoctorIt is worth discussing separately with patients which AI tools they use for their mental health problems.health policyThe need for safeguards on the use of consumer chatbots for mental health is growing.Anthropic expands into life sciences: Johns Hopkins technology, drug discovery and clinical trial designpharmaceuticalsAI support for trial design, document review and molecule search may speed up development steps, but it must be validated.doctorAI-based mapping of tumor tissue points to a new toolkit for pathology and oncology research.AI-drafted patient portal messages do little to ease clinician burnout, as work shifts elsewheredoctorWhen introducing AI scribes and message drafts, measure review time as well as typing time.hospital managerTrack the impact of rollouts with workload measurements, not vendor promises.Surveys: most Americans uncomfortable with AI-assisted diagnoses and insurance decisionsdoctorIn patient communication, it is worth stating the role of AI openly and stressing that a human makes the final decision.hospital managerTransparent communication about AI use is needed to maintain trust.Stony Brook study: AI may make hospital discharge summaries more efficient to producedoctorThe time needed to write discharge summaries may fall, but final review remains with the doctor.
October 2026 · 82
Isomorphic Labs plans human trials soon of AI-designed cancer drugspharmaceuticalsClinical data from the first AI-designed oncology candidates will be an important signal for partnership and licensing decisions.AI agent reads emergency abdominal ultrasounds with 99.6% diagnostic accuracy in studydoctorEmergency physicians and radiologists could interpret ultrasounds faster, but accuracy in a study is not the same as performance in real-world use.medtech companyAI integration in ultrasound devices could become a competitive advantage.NN survey: 46% of Hungarian adult internet users have asked AI for health advicedoctorIn the consulting room, doctors must expect patients arriving with information from AI, and this has to be handled in the consultation.health policyThe measurement could serve as a basis for national patient education and digital health literacy programmes.Flagship merges three biotech platforms into AI drug discovery company EtcelerapharmaceuticalsAnother AI-native player is entering the partnering and acquisition market.Google opens AI research hub in Singapore to support clinicians and health researchdoctorClinicians are the target audience of the new Singapore initiatives.Formation Bio launches $600 million fund to buy clinical-stage drug candidatespharmaceuticalsClinical trial capacity and the price of phase I–II candidates may rise in value, and exit options for smaller developers may improve.Beijing-based BioGeometry raises more than $100M for AI drug discoverypharmaceuticalsCapital flowing to Chinese AI drug-discovery companies is also expanding the licensing and partnering market.Hungarian and Argentine researchers improve uncertainty estimation in image-analysis AIdoctorFlagging uncertainty in radiological AI would help decide when manual review is needed.medtech companyUncertainty estimation could fit the reliability requirements for AI-based imaging tools.Anthropic enters drug development with an acquisition, six industry partners and an IPO filingpharmaceuticalsTarget identification and experiment design could speed up (Mithril's founder estimates days instead of the previous 1–2 months), so a partnership or procurement decision is worth considering.health policyThe entry of general-purpose AI labs into drug research also affects regulatory validation expectations.Microsoft AI system diagnoses 83% of complex cases against doctors' 36%, Science study findsdoctorBased on the simulated tests, the system could serve as a second opinion in difficult cases, but there is no hospital validation yet.hospital managerBefore procurement, ask for a real-patient pilot and a workflow-integration test, not just a benchmark.health ITPlan EHR integration and audit logging for diagnostic agents now.Surveys: many trust chatbots over doctors, but want a human to make the final calldoctorDoctors should expect patients to consult chatbots beforehand, and that trust may affect how consultations are conducted.health policyPublic demand supports keeping human oversight in AI regulation.Surveys: young people often turn to chatbots for emotional difficulties and health questionsdoctorFor psychiatrists and school doctors, AI use should be part of young people's medical history.health policyThe surveys support the need for guidelines on AI and mental health aimed at young people.AI detects "invisible" signs of pancreatic cancer years before diagnosisdoctorFor radiologists, this points to possible early detection and risk-based screening, though validation is still needed.Pharma and AI firms sign $3.8 billion in deals in one monthpharmaceuticalsAI partnerships have become a standard business model; pipeline strategy must decide the balance between in-house and external AI capability.Nurses' daily AI use doubles to 32%, with training shaping attitudeshospital managerNurses' acceptance depends on training, so AI rollouts should be accompanied by education.Insilico's AI-designed cancer drug shows 40% response rate in mesotheliomapharmaceuticalsClinical efficacy data on AI-designed molecules serve as evidence when assessing AI-driven pipelines.Study: AI scribes speed up documentation but did not raise productivityhospital managerThe return on an AI scribe should be measured not by time saved but by additional patients accepted and by satisfaction.doctorThe documentation burden may fall, but an automatic productivity gain should not be expected.AI biomarker improves colorectal cancer treatment decisions; routine data may also enable risk predictiondoctorOncologists may gain a new molecular and AI-based aid for treatment decisions.health policyRisk prediction based on routine data could underpin targeted screening programmes.Agendia validates AI-based digital pathology approach in RASTER cohortdoctorOncologists and pathologists may get a faster or cheaper risk-assessment alternative alongside genomic tests.European network being built to bring AI into cardiologydoctorCardiologists gain an opportunity for shared, multicentre validation.hospital managerJoining the network may offer advantages in data sharing and validation.AI model predicts breast cancer recurrence risk from routine pathology slidesdoctorRisk information extracted from routine slides could support adjuvant treatment decisions.3DQuorum cuts mammography reading time by 13% without reducing cancer detectiondoctorMammography readers' workload could fall while sensitivity stays unchanged.AI-based survival prediction could spare some children high-dose brain radiationdoctorPaediatric oncologists may gain a new prognostic tool for personalising radiotherapy dose, after clinical validation.Microsoft's MAI-DxO in Science: twice as accurate as doctors on hard casesdoctorResults on simulated cases are not yet clinical evidence, so it is worth comparing the sequential, question-asking and test-ordering approach with your own differential diagnosis workflow.health ITThe multi-agent, panel-like architecture is a new pattern for diagnostic support, and integration and validation plans will need to be prepared for it.health policyBecause these systems are said to outperform doctors, clinical validation and liability frameworks need to be developed first.Study warns AI triage could push high-risk emergency patients down the queuedoctorAI triage results should be checked against clinical judgement, especially where input data are biased.AstraZeneca and Oracle to build AI platform for clinical trial recruitment and safety monitoringpharmaceuticalsAI recruitment based on real-world patient data could shorten trial start-up times and serve as a model for redesigning trial processes.doctorTrial sites should expect new enquiries arising from data-driven patient identification.health ITIntegrating real-world patient data with cloud platforms raises the infrastructure demands of clinical research.OpenAI acquires Orchestra Bio, entering drug developmentpharmaceuticalsLarge AI companies are entering the market for drug-development agent platforms directly, creating both partnership and competition.health policyRegulatory questions about AI-developed drug candidates become more pressing.Radical Numerics says first AI-designed phage therapy has reached a human patientpharmaceuticalsThe first use of an AI-designed biological therapy in a human raises new regulatory and manufacturing questions.doctorThe clinical evidence for AI-designed phages remains open and cannot currently be treated as proven.Surveys: most doctors use AI, two thirds a chatbot for medical questionsdoctorUsing AI for clinical decision support is common, so doctors need their own verification practices.hospital managerUnmanaged individual use calls for institutional policies and approved tools.health policyThe high usage rate makes validation and data protection rules more urgent.Study: AI chatbots recognize unnecessary medical tests but falter where doctors disagreedoctorA chatbot's flag can help reduce unnecessary tests, but it should not be relied on in contested cases.Penn Medicine AI model detects hidden diseases in routine CT scansdoctorRadiologists must prepare to handle unrequested, incidental findings and to inform patients.hospital managerSecondary AI analysis of routine CTs raises questions of resources and follow-up.Richter Gedeon discusses validated use of AI and advanced process control in pharmaceutical manufacturingpharmaceuticalsDomestic manufacturers are examining AI in process control built into validated production environments, which requires compliance planning.Mental health chatbots: RAND survey finds nearly one in five young people use themdoctorPsychiatrists and psychologists should ask patients about chatbot use and build it into therapeutic discussions.health policyWidespread chatbot use among young people calls for protective rules.Lilly, Astellas, Novo Nordisk and BMS strike further AI drug discovery dealspharmaceuticalsLarge pharma companies treat milestone-based deals with external AI platforms as part of their R&D strategy.health policyA growing number of AI-driven drug candidates sharpens questions about approval and evidence.AI estimates cancer patients' survival chances and biological age from a single selfiedoctorThe results are at research stage; clinical applicability and privacy risks must be validated.health policyA face photo as health biometric data requires data-protection regulation.AI in pathology and dermatology: lung cancer biomarkers, Lunit–Summit, Mayo ClinicdoctorPathologists and dermatologists can evaluate AI as support for biomarker and biopsy decisions.pharmaceuticalsAI pathology may also play a role in selecting patients for trials and in drug development.Anthropic, Google, ByteDance and Tencent turn to AI drug discovery; Citrini tests ClaudepharmaceuticalsThe entry of technology companies calls for rethinking research partners and supply-chain dependencies.Radiologists' work likely to be reshaped rather than replaced by AI; AI-generated X-rays hard to spotdoctorRadiologists should prepare for work embedded in AI workflows and for the risk of failing to recognise falsified images.hospital managerVerifying the authenticity of imaging data is becoming an integrity issue.Isomorphic Labs raises $2.1 billion; Warp Sciences launches with $215 million; Reflector Bio emerges from stealthpharmaceuticalsCapital for AI-first biotech companies is growing, which means both partnership opportunities and competition.health policyAs AI-designed candidates move toward the clinical phase, preparing for evidence requirements is timely.Pharma industry bets on AI to cut costs and timelines; scaling beyond pilotspharmaceuticalsWhen scaling AI pilots, data readiness should be scored together with business value.HUN-REN SZTAKI develops trustworthy AI for healthcare and industryhealth ITThe domestic research programme is a potential partnership opportunity for developing trustworthy healthcare AI.European AI network launched to support safe management of cardiovascular diseasedoctorFor cardiologists, the network's results may become relevant to future decision support.HUN-REN SZTAKI's new laboratory to develop trustworthy AI systems for healthcare and industryhealth ITDomestic research capacity is being built for trustworthy healthcare AI and can be engaged as a partner.health policyThe domestic research base can inform AI regulation and deployment decisions.AstraZeneca signs $40 million AI drug discovery deal with insitro for cardiometabolic diseasespharmaceuticalsAnother large drugmaker is forming a development partnership with an external AI platform provider, a benchmark for collaboration models.health policyDevelopment targeting liver and heart diseases could affect treatment options in the long term.Radiologists and LLMs fail to spot AI-generated chest x-raysdoctorVerifying the authenticity of images cannot be left to the human eye, so authentication procedures need to be developed.health ITThe image storage and transmission chain may need a mechanism to verify authenticity.First large-scale study shows how doctors use AI in medicinedoctorKnowing actual usage patterns helps doctors compare their own practice with the professional average.hospital managerUsage data can help hospital leaders build the case for institutional policies.Measles outbreak: AI can forecast hotspotshealth policyHotspot forecasts can help target vaccination campaigns.Iambic raises $150M in IPOpharmaceuticalsThe market reception signals investor appetite for AI-based drug developers, which may also affect partnership negotiations.Does private equity ownership affect hospital AI adoption?hospital managerThe link between ownership structure and AI investment decisions is a consideration for strategic planning.More Americans and young people turn to AI chatbots with mental health questionsdoctorPsychiatrists and GPs should ask patients about their chatbot use.health policyDifferent usage patterns among young and disadvantaged groups justify targeted intervention.Philips Future Health Index: AI helps doctors see more patientsdoctorThe report presents reduced documentation burden as the main benefit of AI.hospital managerThis is a vendor survey, so it should be compared against your own data.Mammography AI: models are not interchangeable, hybrid reading could cut workload by about 40%doctorFor radiologists, interchangeability of models is not automatic, and procurement requires local validation.hospital managerReducing screening workload can be significant for capacity planning.Zealand Pharma and Generate Biomedicines sign $1.2 billion AI agreementpharmaceuticalsAI-driven protein design in obesity and metabolic diseases could also speed up partner searches by competitors.Google's AMIE diagnostic chatbot evaluated, with takeaways published Oct. 13doctorLessons from evaluating diagnostic conversational systems can also help physicians shape their own rules for using such tools.HPI: evidence contradicts broad claims about AI and the radiology workforcedoctorData-based analysis is now available in place of predictions about the future of radiology as a career.health policyEvidence should be taken into account when planning training numbers.Can AI help healthcare shift from treatment to prevention?health policyAI use for prevention raises funding and data-protection questions.GSK expands AI drug discovery collaboration with Chai DiscoverypharmaceuticalsThe expansion after the laboratory evaluation signals that protein design models may enter the research workflow.health ITIntegrating the models into research data environments creates new technical requirements.Prostate MRI: AI matches radiologists and could help avoid biopsiesdoctorAI support for biopsy decisions is now a studied option for radiologists and urologists, but on retrospective data.hospital managerFewer unnecessary biopsies may also matter for resource planning.Trial sponsors say AI speeds timelines, but validation and governance lagpharmaceuticalsValidation and governance processes for AI use in trials need strengthening before further rollout.India's TDB backs Peptris with ₹86 crore for AI-driven drug developmentpharmaceuticalsIf Indian AI-based candidates reach clinical phases, it could show how much cheaper discovery is actually worth.Children are left out of medical AI; a new method could helpdoctorFor neonatologists and paediatric radiologists, adult models are not validated for children.medtech companyPaediatric clearance is an untapped market niche.Chinese AI-discovered drug candidates reach regulatory and development milestonespharmaceuticalsAI-discovered candidates from Chinese companies are already entering the stage of clinical trial authorisation.OpenAI quietly posts unpublished life sciences model gpt-rosalind-discoverypharmaceuticalsIt is worth examining how the model compares with research tools already in use and with data protection requirements.Data-driven study of tobacco industry communication to support policy decisionshealth policyThe Hungarian data science centre offers evidence to inform tobacco-control decisions.Study: GPs could have patients assessed by AI chatbots before visitsdoctorThe risk of pre-visit AI assessment is that it could shape the doctor's first impression and the course of the visit.health policyThe risks need to be assessed before chatbots are introduced into primary care.Prospective feasibility study of AMIE conversational diagnostic AI published in The LancetdoctorThe AI can take the medical history before the visit, which affects the length and structure of the appointment.hospital managerA pre-screening chatbot could affect how outpatient care and the patient pathway are organised.health ITIntegrating conversational diagnostic systems into patient intake is a new task.Analysis: AI-enabled drug discovery pipeline is growing but remains largely early-stagepharmaceuticalsThe early-stage nature of the pipeline warrants cautious expectations about the success rates AI promises.Missing chatbot records leave doctors unable to trace harm from AI health advicedoctorDoctors should ask patients about AI advice, because without documentation they cannot see what was said.health policyThe lack of chatbot logging and traceability points to a regulatory gap.AI companies run virtual drug trials to improve success of human studiespharmaceuticalsVirtual trials target pre-clinical screening and lower dropout rates, so it is timely to assess the providers.Charm doses first patient with AI-designed menin inhibitorpharmaceuticalsAI-designed molecules entering clinical phases are the first real test of how effective AI-driven research is.doctorFor oncologists, menin inhibitors open up a new trial option.Danaher launches AI-powered autonomous drug discovery lab; Carterra announces new collaborationpharmaceuticalsAutomated, AI-in-the-loop labs aim to speed up the research cycle, so supplier offerings are worth watching.Bosch–Richter survey: Hungarians open to AI and health technologyhealth ITPublic openness signals an opportunity for adoption in the market for digital health services.health policyThe survey can be used to gauge public receptiveness in digital health planning.Three-quarters of FDA-authorized AI medical devices are in radiology; real-world study finds more brain aneurysms detecteddoctorRadiologists need to judge the accuracy and time savings of AI tools, and the RSNA offers training for this.medtech companyRadiology is the main area of AI authorizations, so competition is strongest here.EU puts €20 million into cardiology AI as CHAIN network launchesdoctorCardiologists can join the research network, which aims at the safe clinical use of AI.health policyThe federated ecosystem could serve as a model for EU-wide AI adoption.health ITThe project provides a basis for developing data-sharing and interoperability solutions.Isomorphic Labs reportedly seeking funding at $40–50 billion valuationpharmaceuticalsHuge valuations for AI-native drug developers could redraw the partnership and competitive landscape.Randomised study: AI chatbot helps laypeople assess respiratory symptoms better than web searchdoctorPatients increasingly assess their symptoms with AI, so it is worth knowing when this leads to appropriate care-seeking.health policySymptom-assessment chatbots could complement patient routing and messaging systems.Virtual biotech staffed by 37,000 AI agents finds marker for more successful medicinespharmaceuticalsThe agent-based research model points to a new methodological direction in candidate selection.PwC: consumer use of AI in healthcare is spreading fast in Romania, with income the main obstaclehealth policyThe fast spread of consumer AI use and the income barrier can inform care-policy decisions in the region.Disclosing AI use lowers trust in doctors, especially among younger patientsdoctorDoctors should think carefully about how they disclose AI use, as trust may fall and advice may be followed less.hospital managerPatient information on AI use requires a communication protocol.AI took better medical histories than residents in a randomised trialdoctorParts of history-taking can be handed to AI, which affects training and residents' work.Hospitals team up to speed advances in diagnostic AIhospital managerJoining hospital consortia may help with access to data and validation.How does an AI pathology tool become a companion diagnostic?pharmaceuticalsFor companion-diagnostic AI, the path from research use to clinical access requires accreditation.medtech companyThe companion-diagnostic route opens a market opportunity for AI pathology tools.
September 2026 · 81
NHS study: AI skin cancer tool reduces number of biopsiesdoctorFor dermatologists, the AI tool can help safely triage benign cases.hospital managerFewer biopsies can free up capacity.Medical AI devices should be tested in real-world settings, but most in hospitals are nothospital managerWhen procuring, it should ask the manufacturer for validation data from real-world conditions.medtech companyIt should collect performance data in clinical settings, including after authorisation.health policyPost-market evaluation based on real-world use is a regulatory question.Tremont AI emerges from stealth with AI platform for preclinical drug safetypharmaceuticalsAI-based safety prediction can be built into the preclinical toxicology workflow.AI chatbots and mental health: studies warn of psychological harmdoctorPsychiatric and primary-care histories should include questions about chatbot use.health ITMental health AI products need risk management and safety controls.AI plus one radiologist matches two radiologists in breast cancer screening, analysis findsdoctorReplacing the second reader with AI could mean a change in screening protocols for radiologists.hospital managerReorganising screening with AI could help address radiology capacity shortages.health policyThe study is an argument for reviewing screening guidelines to allow AI-supported reading.Radiology: generative AI compared with physicians, and wrong AI suggestions bias readersdoctorAI suggestions can steer decisions in the wrong direction, so AI should not be used as an automatic anchor.AbbVie partners with IPO-bound Iambic as Insilico picks another AI-designed obesity drug candidatepharmaceuticalsAI-led research partnerships and AI-designed candidates are also appearing in large companies' portfolios.FDA grant funds an LLM "jury" to evaluate AI-generated radiology reportsdoctorAssessing the quality of generated radiology reports could become standardized.medtech companyThe FDA's interest in evaluating report-generating AI signals future expectations.AI detected esophageal cancer on CT scans months before diagnosis, study findsdoctorOpportunistic AI analysis of routine CT scans could allow earlier detection, if the result is confirmed clinically.New AI test aims to diagnose diabetes in seconds from voicedoctorVoice-based screening could offer pre-screening without blood draws, but clinical confirmation is needed.Independent analysis: Medable's AI agent saves millions in clinical trial costspharmaceuticalsMonitoring trials with an AI agent could bring cost and time savings.Roche plans move towards autonomous AI-driven laboratories in drug developmentpharmaceuticalsLinking laboratory automation with AI-based design could become a competitive factor.HUN-REN SZTAKI presents AI for premature infants' development at Singapore's Medical Fair Asia 2026doctorA Hungarian development usable in neonatology has been showcased on the international market.medtech companyPresenting domestic research institute developments at international exhibitions may open up market contacts.AI analysis reveals little-known side effects of GLP-1 analoguesdoctorDoctors prescribing GLP-1 analogues should watch for the new side-effect signals, after checking the details.pharmaceuticalsAI-based drug-safety analysis may affect pharmacovigilance processes.Enveda raises $311m and Basecamp Research $140m for AI drug discoverypharmaceuticalsThe inflow of capital supports AI biotechs' move into the clinical stage, so competitor monitoring should track these candidates too.AI model predicts pancreatic cancer risk three years before diagnosisdoctorEarly risk estimation could affect screening strategies, but clinical validation is needed.medtech companyPredictive models open a new development direction for cancers that are hard to screen for.Medical AI benchmarks: Carnegie Mellon's 'Synthetic Hospital', MLCommons and AMIE authors' critiquedoctorA model's benchmark results do not demonstrate clinical reliability with long patient records.health ITAI procurement should require local testing on real data.Insilico doses first patient in Phase III trial of AI-designed lung disease drugpharmaceuticalsAn AI-designed molecule reaching Phase III sets a benchmark for expectations on efficacy and timelines.doctorA new AI-originated active substance may join the future treatment options for lung diseases.Studies: AI scribes could ease documentation burden for doctors and nursesdoctorAmbient documentation could help against burnout, but rollouts should be measured.hospital managerAdoption decisions should rest on measured burnout and time-saving indicators.More people ask AI about health: it supplements research and may signal anxietydoctorIn consultations, doctors should ask about chatbot use and watch for possible anxiety.Radiology studies: AI in chest and abdominal CT reporting, with shorter reading timesdoctorRadiologists need to validate the effect on reporting time and sensitivity in their own workflow.AbbVie forms AI drug discovery partnership with Iambic, which is preparing a stock market listingpharmaceuticalsBig pharma partnerships with AI biotechs reinforce the pattern of outsourcing early-stage research, so companies should review their own partnership strategy.Mental health chatbots fall short with children as therapists urge cautiondoctorDoctors should routinely ask patients about chatbot use and know the signs of AI psychosis.health policyRegulatory steps to protect children and young people may come onto the agenda.New pharma–AI partnerships: Novo Nordisk–Anthropic, Lilly–Twist, Boehringer Ingelheim–EnvisagenicspharmaceuticalsContracts with AI companies are multiplying quickly, so it is worth setting terms for target identification and data sharing proactively.Study: AI could cut medical device recalls by nearly a thirdmedtech companyUsing AI tools in quality assurance and post-market data analysis could lower recall risk.health policyAI-based early warning could also be built into regulators' market surveillance tools.AI in cancer diagnostics: recurrence prediction, bladder cancer risk, oral tumours, a pathology engine and breast screeningdoctorDoctors should follow developments in pathology and screening AI tools; validation data are needed before clinical adoption.medtech companyBreast screening AI heading into final clinical trials and new pathology engines are sharpening product competition.AWS research: European healthcare uses AI more deeply and responsibly than most sectorshealth ITThe survey offers a benchmark, but its source is a vendor with a commercial interest.Emergency triage: AI support improved classification accuracy and patient flowdoctorAI triage may have a measurable effect in emergency departments, but local validation is needed.University of Szeged to develop HUF 39 million imaging diagnostics teaching systemdoctorImaging diagnostics training may gain a new tool from SZTE.health policySupport for medical education development may affect Hungary's imaging diagnostics capacity.Alibaba open-source AI model detects nearly 150 conditions, outperforming 23 of 26 radiologistsdoctorOpen models that outperform radiologists warrant local validation.medtech companyAn open-source model with broad coverage may put pricing pressure on closed vendors.Multicentre mammography study: adjunctive AI raises breast cancer detection by more than 10 percentdoctorThe result supports AI assistance in screening programmes, but the short follow-up calls for caution in interpreting it.Anthropic sets up a biology lab, says it is not specifically for drug researchpharmaceuticalsAn AI developer is building its own laboratory, which could reshape the division of labour between model providers and pharmaceutical companies.Virtual biotech puts up to 37,000 AI agents to work on drug discovery, with lung cancer candidatepharmaceuticalsThe multi-agent framework points to automation of target identification and development planning, which makes pilot testing of research workflows worthwhile.New AI-based test predicts breast cancer recurrence risk more accuratelydoctorA more accurate estimate of recurrence risk can support treatment decisions.AI scores lung cancer treatment response on par with pathologistsdoctorPathology scoring could be partly automated, while validation remains the pathologists' task.Novo Nordisk to use Anthropic's Claude in drug researchpharmaceuticalsA major drugmaker is publicly building its research on a large language model, which gives competitors a benchmark for their own AI strategies.GenScript and Twist join Eli Lilly's TuneLab AI platformpharmaceuticalsUnder the TuneLab model, contract partners supplying experimental data become integral parts of AI platforms, which matters when selecting CRO partners.ByteDance AI drug discovery unit Anew Labs raises $290M at $1.5B valuationpharmaceuticalsA technology giant's spun-off AI unit is entering drug discovery with substantial capital, a matter for partnership planning and competitor monitoring.Studies find AI scribes cut doctors' documentation time and burnoutdoctorThe time savings can be backed with data, so they provide a reference point in applications for institutional rollout.hospital managerThe return on investment and the effect on burnout can be argued in the purchasing decision.health ITIt is worth defining the evaluation metrics in advance.Nearly one in five young people turns to AI for mental health advicedoctorWhen questioning young patients, it is worth mapping their AI use as well.health policyWidespread chatbot use among young people strengthens the case for regulation.AI can also detect common cardiovascular diseases from mammogramsdoctorScreening mammography could provide an additional risk signal, which affects cooperation between radiologists and cardiologists.Insilico launches AI-driven longevity vaccine research for age-related diseasespharmaceuticalsA new therapeutic area opens for AI researchers, but the programme is at an early stage.Else Kröner Fresenius Center for Digital Health presents on-premise medical AI agent for clinical decision supporthealth ITFrom a data-protection standpoint, an on-premise model is an alternative to cloud-based solutions.Virtual cell model predicts effective drug for triple-negative breast cancerpharmaceuticalsCell-model-based prediction can support candidate selection and trial design.AI and personalised medicines on the agenda at Bosch and Richter conferencepharmaceuticalsA leading player in Hungary's pharmaceutical industry is discussing the link between AI and personalised therapies at a public professional forum.Evidence for medical AI effectiveness is lacking: only 34 of 1,357 FDA-authorized devices registered for prospective studiesdoctorRegulatory authorization alone is not evidence of clinical effectiveness, so when choosing a device it is worth asking for prospective data.hospital managerProcurement should require real-world clinical validation.medtech companyThe lack of prospective evidence is a market and credibility risk.health policyPressure for regulatory requirements on proof of effectiveness may grow.Drug firms' proprietary data boost AI protein modelspharmaceuticalsProprietary data is a competitive advantage in model training, so data-sharing and federated learning collaborations are worth considering.AI tool predicts lung cancer immunotherapy outcomes; human-AI collaboration also testeddoctorFor oncologists, AI can supplement therapeutic decisions; the study also measured human-machine collaboration.Most oncology nurses have had limited AI training but want to learn; 92% of nursing students have used ithospital managerThe lack of AI education for nurses is a risk for deployments.Insilico's AI-discovered drug rentosertib enters phase 3 in idiopathic pulmonary fibrosispharmaceuticalsOne of the most closely studied AI-discovered molecules has reached the pivotal stage, which may serve as a benchmark for evaluating AI-derived pipelines.Moderna and Merck's AI-built cancer vaccine clears phase 3, PYMNTS reportspharmaceuticalsIn personalised mRNA therapy development, the role of AI may be validated at the pivotal stage, so platform strategy deserves reassessment.Microsoft study: AI diagnosed complex cases better than experienced physiciansdoctorThe value of differential-diagnosis support is demonstrable, but performance in a hospital setting needs to be measured separately.Is AI accelerating drug discovery? Two-molecule data and a JCIM analysispharmaceuticalsThe findings offer a critical benchmark for internally validating AI promises in lead optimisation.AI spatial analysis of standard pathology slides predicts pancreatic cancer recurrencedoctorRoutine slides can yield additional prognostic information without a separate test.Korean-US multinational study: AI improves stroke diagnosisdoctorIn emergency stroke diagnosis, AI support can save time.Patients use AI to interpret symptoms and prepare for medical appointmentsdoctorPatients arrive at the surgery with information obtained from AI, and this needs to be handled in the consultation.Romanian researcher joins team developing AI-based child psychiatric diagnosis systemdoctorAI support for child psychiatric diagnostics aims to shorten the long road to a diagnosis.AI trained to think like pathologists may better detect cancer; new assistant reads whole slidesdoctorFor pathologists, models that give their reasoning are easier to audit, but they are not yet clinically validated.medtech companyExplainable, step-by-step reasoning models can be a differentiator in the digital pathology market.AI analysis of pathology slides may help assess risk of pancreatic cancer recurrencedoctorOncologists and pathologists can watch for a new slide-based prognostic signal of recurrence risk.medtech companyPrognostic AI is another application area for diagnostic software.Teens increasingly turn to AI chatbots for mental health supportdoctorMental health professionals should ask young people about their AI use during assessment.health policyPressure is growing for AI regulation affecting minors.Novo Nordisk and AWS form strategic partnership to accelerate AI-driven drug discoverypharmaceuticalsLarge companies are building R&D on cloud AI platforms, which affects supplier and data-management decisions.Fewer than 1% of FDA-cleared AI devices tested for clinical benefithospital managerIn procurement, ask the vendor for patient outcome evidence rather than accepting FDA clearance alone.doctorClearance does not mean proven clinical benefit, so a device's results should be treated critically.medtech companyA lack of patient outcome data can be a competitive disadvantage in evidence-based purchasing.Pharmahungary Group develops microRNA therapy with artificial intelligencepharmaceuticalsA Hungarian company is bringing AI into microRNA-based therapy development.AI-discovered rentosertib lowered biological age on six aging clocks in lung disease trialpharmaceuticalsUsing aging clocks as secondary endpoints is a new trial-design option, but it needs validation.doctorWhen answering pulmonary fibrosis patients, present the aging-clock result as biomarker data, not as evidence of clinical benefit.health policyWhether regulators will accept biological age as an endpoint will sooner or later reach the agenda.Insilico's rentosertib enters Phase III trialpharmaceuticalsThis is the first major test of whether an AI-discovered molecule can also succeed in the pivotal phase.doctorFor pulmonologists, Phase III will provide the real efficacy and safety data.AI chatbots dropped correct sleep apnea referral advice a third of the time when patients pushed backdoctorHandle patients' chatbot-sourced "confirmation" by asking follow-up questions, as the model may give in to pressure.health policySafety testing of consumer health chatbots needs scenarios with resistant patients.nPhase, IQVIA and others rebuild clinical development around AI, data foundations and agentspharmaceuticalsPutting trial data foundations and governance in order is a prerequisite for adopting AI.AI drug discovery hits a new bottleneck: experimental validationpharmaceuticalsExperimental validation capacity must be planned together with AI candidate generation.AI model outperforms radiologists on subtle hip fractures; study finds 39% more brain aneurysms detecteddoctorIn radiologist workflows, AI as a second reader can raise detection rates, but its effect on patient outcomes has to be demonstrated separately.Study: AI chatbots wrongly reassure sleep apnoea patients in a third of casesdoctorChatbot reassurance can delay diagnosis, so it is worth asking patients about AI use during history-taking.AI model flags colorectal cancer on routine noncontrast CT scansdoctorFor radiologists, AI could flag colorectal cancer as an incidental finding on routine CT, after clinical validation.hospital managerOpportunistic AI screening could build on existing imaging capacity.Only one in four Hungarians is satisfied with healthcare; 48 percent hope for faster AI diagnosishealth policyDissatisfaction together with the hope for faster AI diagnosis points to public support for digital developments.hospital managerPatient expectations point towards faster, AI-supported care.Study: AI scribes may miss patients' experiences and cause deskillingdoctorPatients' accounts of their experiences should be deliberately recorded during the consultation, because the AI transcript may omit them.hospital managerWhen introducing AI scribes, attention is needed to preserving documentation skills and to measuring patient experience.health ITWhen evaluating an AI scribe, content completeness should be measured alongside time savings.Survey: nearly half of Hungarian internet users have already asked AI a health questiondoctorPatients increasingly arrive with information and self-diagnoses from AI, which must be addressed during consultations.health policyPublic use of AI justifies health information and health literacy programmes.health ITThe data on Hungarian user trust can inform the design of Hungarian-language health AI products.Owkin signs AI drug discovery deal with Boehringer Ingelheim for cancer and immunologypharmaceuticalsThe collaboration model shows that large companies are expanding their research pipelines with external AI platforms.Studies: AI scribes cut doctors' administrative timedoctorAn AI scribe likely cuts documentation time substantially, but time for review must be planned in.hospital managerThese figures can support an institutional business case, but return on investment should also be measured in a pilot in your own environment.Insilico Medicine releases frontier AI models for drug discoverypharmaceuticalsResearch teams should evaluate the new models against their own target and molecule identification workflows.ASCO: clinical AI needs more and better benchmarksdoctorThe lack of independent benchmarks calls for caution when evaluating oncology AI tools.Blind spots found in ChatGPT Health's medical triagedoctorConsumer AI triage can be wrong, so patients should be educated about the limits of using it.Semmelweis University workshop on machine learning in public health under HAI-SO projecthealth policyPublic health AI models are being developed to support decisions on health system optimisation.hospital managerThe project's results can be used in institutional planning.Semmelweis University: structured data and AI to improve dental caredoctorStructured documentation is a prerequisite for AI support in dentistry as well.health ITStructured data models can provide the basis for AI development.
August 2026 · 74
Studies link AI chatbot use to loneliness and emotional problems among young peopledoctorIt is worth discussing with young patients why and how often they use AI chatbots.Transluce publishes 50,000-plus simulations testing how AI systems handle mental health crisesdoctorMental health professionals need to know how chatbots handle crises before recommending them to a patient.health ITDevelopers and integrators must test how AI chatbots handle crisis situations.Of 1,357 FDA-cleared AI devices, only three were tested on patientsdoctorClearance of operating-room AI tools does not mean effectiveness has been shown in patients, so clinicians should ask separately for clinical evidence.medtech companyThe lack of clinical validation risks tighter expectations from regulators and buyers.hospital managerAt procurement, hospitals should ask manufacturers for prospective patient studies.New AI drug discovery tie-ups and projects: Ono–Aitia, Hiro, MND, JapanFoldpharmaceuticalsThe partnerships and local data-handling arrangements offer examples for procurement and partner-selection decisions.Imaging and pathology AI research: ATTR-CM, coronary CT, breast cancer, HCC, SlideChat, endometriosisdoctorThe new studies show directions for diagnostic decision support, but validation is needed before clinical use.AI drug discovery draws doubts as venture bets yield little and most drugs still failpharmaceuticalsWhen investing in AI, companies should ask platform vendors for evidence measured in clinical success rates.AI analysis of facial video explored as a way to flag hypertension, diabetes and heart diseasedoctorRemote, contactless screening deserves attention, but clinical validation should be awaited.AI in digital dermatoscopy may improve diagnostic performancedoctorFor dermatologists, AI decision support can improve diagnostic accuracy when it assists the physician's decision.AI analysis of mammograms can also detect heart disease in women, study suggestsdoctorSecondary analysis of screening images could provide a new cardiovascular risk signal, but it requires clinical validation.hospital managerData from existing screening programmes could add value if AI analysis can be built into the workflow.medtech companySecondary risk estimation based on screening imaging is a new product area.AI drug discovery: benchmark flaws may distort leaderboards, as CIOMS issues pharmacovigilance validation standardspharmaceuticalsVendor claims based on benchmarks should be verified independently; a validation standard is now available for pharmacovigilance AI.health policyThe CIOMS standard could serve as a basis for regulatory expectations on pharmacovigilance AI.Faro raises $37 million to speed up clinical trials with AIpharmaceuticalsAI built into protocol design and patient recruitment can cut the time and cost of trials.AI cancer detection results: bladder, liver and lung nodules, plus an Estonian studydoctorThe results point toward earlier detection and fewer missed cases, but the clinical trial details will decide the strength of the evidence.hospital managerJustifying pilots of AI-based screening support requires measurable sensitivity and false-positive data.Survey: patients want to know when their care provider uses AIhospital managerIt is worth drawing up a patient-information rule on when and how to disclose the use of AI.doctorInforming patients about the use of AI can be part of doctor–patient communication.health policyPatient expectations support the case for AI transparency rules.Pew: more than a third of Americans have turned to an AI chatbot for health advicedoctorPatients increasingly arrive with information from a chatbot; this has to be handled during the visit.health policyThe scale of public chatbot use justifies regulatory and patient-information steps.Survey: physicians want higher pay from AI productivity gainsdoctorAI use can become an argument in pay negotiations.hospital managerHow productivity gains are shared must be decided before deployment.health policyAI-driven productivity is part of workforce retention and pay policy.Analysis: FDA's AI device list holds 1,430 authorized devices for 1995–2025medtech companyThe specialty distribution shows which clinical areas are crowded or still empty in the AI device market.health policyThe registry analysis provides data for regulatory monitoring of how AI devices spread across specialties.Cluj research: where AI stands in drug discoverypharmaceuticalsThere is a gap between AI promises and real results; projects need realistic expectations.AI drug discovery: Nvidia backing, Novo Nordisk–AWS partnership and Insilico resultspharmaceuticalsLarge companies, cloud providers and AI startups are dividing up the work; partnership strategy must be aligned with this.health policyPhase III results for AI-designed candidates will shape how the sector is perceived.Behavioral health AI: Onos Health raises $17 million, chatbot therapy rated, triage concernsdoctorA chatbot may suit basic therapeutic conversation but is weak at applying specialised techniques consistently, and triage delays pose a danger.health ITSafety checks are key when deploying AI triage in mental health care.health policyLawsuits and FDA consultations are pushing for regulation of mental health AI.Radiology AI: cognitive biases, risks of ruling out findings and misidentified AI imagesdoctorUsing AI as a rule-out tool is risky; the verification steps in reporting must be deliberately kept.hospital managerWhen deploying AI, accuracy must be measured alongside speed gains.medtech companyTesting devices for human factors and biases is becoming an expectation in their evaluation.Survey: 87% of Hungarians would support the use of AI in healthcarehealth policyStrong public support provides a social basis for AI adoption, but trust must be built on transparency.hospital managerPatients' openness makes it possible to launch AI pilots, together with patient information.doctorPatients' expectations of AI must be taken into account in the consulting room as well.Index: Hungarians complain about public healthcare, nearly nine in ten would back AIhealth policyPublic support could give AI rollout a social base, while dissatisfaction with care adds urgency to improvement.hospital managerPatient openness could make it easier to communicate rollout pilots.SandboxAQ launches AI tool to cut cost of early-stage drug discoverypharmaceuticalsA new AI tool is available for early-stage research.Reviews examine mental health risks of AI chatbots, including amplified delusionsdoctorPsychiatrists should ask patients about their chatbot use, especially when delusional or manic symptoms are present.health policyThe evidence supports setting safety requirements for chatbots.Bristol Myers Squibb partners with Chai Discovery on AI antibody designpharmaceuticalsLarge companies increasingly rely on external AI biotech partners for antibody design.Filament Health signs letter of intent with Darmiyan to explore BrainSee AI in early Alzheimer's trial designpharmaceuticalsAn authorized AI tool could also play a role in selecting patients for trials.Tufts–Medable: AI agents could deliver $21m net benefit per programme in clinical trialspharmaceuticalsFor the business case, the figure should be recalculated for the company's own programme structure.PolyU team develops TRUECAM framework for more reliable pathology AI in cancer diagnosisdoctorFor pathologists, frameworks that measure reliability can help in assessing AI-generated findings.93% of hospitals use AI, but only 44% have tested it properlyhospital managerA formal process is needed to test and oversee AI tools.health ITA validation and monitoring framework must be built for the tools in use.doctorThe AMA urges guardrails for the use of AI in healthcare.TCS launches agentic AI platform for drug development and clinical trialspharmaceuticalsAgentic automation options should be mapped with trial sponsors and CRO partners.Clinical evidence for AI drug discovery remains 'disappointingly limited' after a decadepharmaceuticalsFor AI-based projects, clinical-level metrics should be specified to justify the investment.Mayo Clinic AI detects pancreatic cancer signs on CT scans originally read as normaldoctorThe tool is not yet ready for clinical use, but it shows the potential for early detection.medtech companyProspective validation is needed before market entry.Rural hospitals are slow to adopt AI, and patients are waryhospital managerRural institutions need to treat building patient trust as part of the rollout.Novo Nordisk–AWS partnership and Takeda bet add to AI drug discovery investmentpharmaceuticalsCloud AI partnerships point to faster research and outsourced infrastructure.European projects aim to speed up the use of AI in hospital oncologydoctorThe European oncology projects point to the direction of later clinical use.Wearable sensors combined with AI enable non-invasive blood pressure monitoringdoctorContinuous blood pressure monitoring may support follow-up at home.Dartmouth study: AI helps doctors sound more empathetic but overdiagnoses and overtreatsdoctorAI suggestions are best used for communication, while diagnostic and treatment suggestions should be treated critically.MRC-funded £20m Cambridge hub to use AI to develop new medicinespharmaceuticalsThe academic AI hub could offer opportunities for collaboration.Evaxion adds AI-designed off-the-shelf glioblastoma vaccine EVX-05 to pipeline, drops EVX-03pharmaceuticalsThe company is focusing on AI-designed candidates, and the pipeline reshuffle is a signal to the market.AI model predicts gene mutations and biomarkers from tissue images across 32 cancer typesdoctorBiomarkers estimated from histology images can complement molecular testing but do not replace it.Dartmouth's Therabot is first generative AI mental health chatbot with clinical resultsdoctorAn AI therapy tool backed by clinical evidence could become part of stepped care and waiting-list management.health policyThe clinical trial result may carry weight in how AI therapy is judged by regulators.Nordic AI-Health Initiative outlines federated data infrastructure for medical AIhealth policyThe model of federated, cross-border data sharing is instructive for the European Health Data Space as well.health ITGuidance may be drawn from it for designing federated learning and data infrastructure.STADA Health Report 2026: Hungarians more open to AI than the European averagedoctorDoctors should be ready in the surgery for patients' use of AI and the preliminary information they gather from it.health policyHigh openness may increase pressure for frameworks on patient information and AI regulation.pharmaceuticalsPublic use of AI justifies a rethink of patient communication channels.Tufts CSDD: AI agents can deliver up to $21 million net value and 82x ROI per drug development programmepharmaceuticalsThe figures offer a benchmark for a business case when procuring AI agents for clinical trials, but they should be checked against a company's own programme data.AI-designed universal coronavirus vaccine tested in humans, reported safe and effectivepharmaceuticalsHuman data on the AI-designed vaccine strengthens validation of AI-based vaccine design.doctorThe results are preliminary; they do not yet change vaccination practice.Controlled clinical validation study benchmarks AI models for differential diagnosis of oral mucosal lesionsdoctorComparative data on AI models are now available for diagnosing oral lesions.Semmelweis University PhD study surveys healthcare professionals' attitudes to AIAI tools may fall short of breast radiologists' expectations in practicedoctorIn breast screening, AI should be validated in the local workflow before its benefit is counted on.hospital managerWhen procuring mammography AI, hospitals should ask for prospective evidence.Google's AMIE medical AI conducts real-time video consultationsdoctorThe diagnostic dialogue AI is expanding to video consultations, which may affect telemedicine practice.health ITMultimodal medical AI is a future integration question for telemedicine platforms.Novo Nordisk picks AWS as strategic partner for AI drug discovery; London hub to openpharmaceuticalsThe partnership between a major drugmaker and a cloud provider is a benchmark: companies should assess how ready their own discovery data and computing capacity are for a similar collaboration.health ITBig pharma demand for cloud-based discovery infrastructure presents an opportunity for suppliers.AI clinical decision support is spreading faster than the evidence behind itdoctorTreat AI suggestions critically, because physicians too can come to lean on machine classifications.hospital managerDeployment requires validation and monitoring on the hospital's own patient population.health policyEvidence standards will have to be developed to keep pace with the speed of adoption.Aureka raises $100M Series B for AI drug discovery; Isomorphic Labs reportedly secures $2.1 billionpharmaceuticalsCapital flowing to AI-native biotechs increases partnership and competitive pressure.medtech companyFunding dynamics in AI drug discovery also affect the supplier ecosystem.Evotec and Almirall sign AI drug discovery deals as tech capital pushes fail-fast developmentpharmaceuticalsThe contract and milestone terms of AI-biotech partnerships should also be weighed against the expectations of tech investors.Redesign Health study: 71% of health systems follow an 'Epic-first' AI purchasing strategyhealth ITIn AI procurement, the EHR vendor's offering is the first filter, so third-party solutions must prove their integration.hospital managerIT budget planning must account for pressure to buy AI from the EHR vendor.medtech companyStartups must solve how to fit into the EHR vendors' ecosystems.Insilico Medicine nominates AI-designed ISM9077 for eye diseases, partners with THPharma on THP-001pharmaceuticalsInsilico's case illustrates a strategy that uses AI from target nomination through to rethinking assets at phase 3.AI drug discovery under scrutiny as AI-designed drugs enter human trialspharmaceuticalsNews of AI discoveries should be measured against clinical results.NHS AI Lab study examines system-level barriers to scaling AI; workforce to be redesigned, not replacedhospital managerBarriers to scaling AI are organisational, not just technical.health policyLessons on scaling can be applied to AI programmes in other health systems.AI tool trained on 97,000 patients reportedly finds Alzheimer's cases doctors miss, especially in minority patientsdoctorIn dementia screening, AI can provide a supplementary flag for missed cases, subject to validation.Stanford researchers design 16 new viruses with AI, raising biosecurity concernshealth policyA regulatory and safety framework is needed for the dual-use risk of generative biology.pharmaceuticalsA new tool may emerge for research on drug-resistant pathogens, under strict biosafety conditions.Schrödinger and Bristol Myers Squibb sign deal on agentic AI drug discoverypharmaceuticalsA large drugmaker is deploying an agentic research tool as contracted software, which raises the question of rethinking internal research workflows.Generative biology is rewriting the rules of drug discovery, analysis sayspharmaceuticalsGenerative models are becoming part of research strategy, so skills and data should be planned ahead of time.Hassabis steps back from DeepMind to focus on Isomorphic LabspharmaceuticalsOne of the flagship AI drug-discovery ventures is getting leadership attention, which could affect partnership talks.Recursion works with Genentech on first validated neuro target found through its AI mappharmaceuticalsValidation of a target found through the AI map and the scale of the partnership gauge how mature platform-based target discovery has become.MIT study: medical AI's benefits depend on user expertise, with novices at greater riskdoctorWhen younger, less experienced colleagues use AI, a separate verification step should be set up, as they face the greatest risk of being misled.hospital managerWhen introducing AI support, protocols and supervision should be differentiated by training level.health ITExplanations in AI interfaces do not replace validation, so the presentation should be tested by user level.QuantHealth raises $45 million to run AI simulations of clinical trialspharmaceuticalsIn the trial-design phase, simulation tools can screen out designs prone to failure before patients are enrolled.AI-designed drugs advance in trials with no US approval yet; proof is the bottleneckpharmaceuticalsResearch time savings do not automatically convert into a regulatory advantage, so clinical development plans need separate reinforcement.health policyRegulators still expect clinical evidence from AI-originated candidates.AI breast cancer screening: DBT scores, 2D mammography risk assessment, startup grantsdoctorRadiologists need to learn the clinical interpretation of AI scores in screening and the new options for risk-based screening.medtech companyEarly-stage companies are using grant funding to move toward regulatory approval.H1 and Novo Nordisk partner on AI-driven clinical developmentpharmaceuticalsThe data-platform partnership may also offer a model for AI support in investigator and site selection.Phylo and Chugai partner on AI agents for drug discoverypharmaceuticalsAgentic AI tools are appearing in research workflows with another major partner.AI use for mental health support is rising among young peopledoctorPsychiatric and psychological care should routinely ask young patients about their chatbot use.health policyThe data on students can be used to plan prevention and school programmes.AI diagnostics research: liver cancer blood test, bowel cancer relapse risk, Parkinson's eye scans, sleep studiesdoctorThe studies point to widening screening and risk-assessment methods, and their clinical use requires further validation.Scoping review examines AI-based nurse schedulinghospital managerThe review offers guidance for drawing up requirements before deployment.GSK to pay Relation Therapeutics up to $110 million for AI data and modelspharmaceuticalsLicensing AI models and datasets is becoming a separate procurement channel for expanding the research portfolio.AI aids bone tumour X-ray diagnosis with AUC 0.96; prostate radiation dose mapped in secondsdoctorClinical use of imaging and radiotherapy AI tools may spread after further validation.